The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Changing perceptions of MGUS progression: explaining the data
Ola Landgren
• 12 Sep 2019
Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into the progression of monoclonal gammopathy (MGUS) into multiple myeloma (MM), and the findings which indicate that risk assessment needs to be carried out more frequently. He also highlights how not all MGUS goes through a smoldering myeloma phase. This interview took place at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
